You absolutely can. Where is the restriction? It's common for pharmaceutical companies to synthesise competitor compounds to get a read on invivo PK/PD etc. And this isn't a clinical study so this isn't a case of anything unprofessional or rushed, it's a simple lab experiment. I'm not questioning if either have GMP product, obviously they do as the are running studies... but it's not required to put in a dish with some cells and it's misguided to beleive this indicates an ongoing collaboration
- Forums
- ASX - By Stock
- Ann: DMX-200 Competitive Position Further Enhanced
You absolutely can. Where is the restriction? It's common for...
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
43.5¢ |
Change
-0.015(3.33%) |
Mkt cap ! $239.5M |
Open | High | Low | Value | Volume |
43.5¢ | 43.8¢ | 42.0¢ | $988.7K | 2.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.5¢ | 17061 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.430 |
4 | 162352 | 0.425 |
14 | 308110 | 0.420 |
8 | 226373 | 0.415 |
8 | 199251 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 17061 | 1 |
0.440 | 17062 | 1 |
0.445 | 45000 | 2 |
0.450 | 218895 | 3 |
0.455 | 45000 | 1 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |